US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Daiichi Sankyo Co., Ltd.

19.02

+0.85974.73%

Post-market: 19.00-0.0197-0.10%16:00 EST

Volume:915.08K

Turnover:17.32M

Market Cap:35.20B

PE:25.61

High:19.04

Open:18.57

Low:18.57

Close:18.16

52wk High:28.21

52wk Low:17.80

Shares:1.85B

Float Shares:1.81B

Volume Ratio:0.50

T/O Rate:0.05%

Dividend:0.44

Dividend Rate:2.33%

EPS(TTM):0.7425

EPS(LYR):0.6921

ROE:18.27%

ROA:5.46%

PB:3.21

PE(LYR):27.48

Loading ...

Overview Company News Filings

Daiichi Sankyo Co Q4 EPS $0.30, Same YoY, Sales $3.623B Up From $3.401B YoY

Japanese Stocks Climb 1.5%

AstraZeneca, Daiichi Sankyo Drug Gets U.S. Nod for Breast-Cancer Label Expansion

Japanese Stocks Climb 1.1%

AstraZeneca, Daiichi’s Datroway demonstrated significant improvement in OS, PFS

Japanese Pharma Stocks Could Gain on Revived Investor Sentiment -- Market Talk

AstraZeneca shares leap with FDA set to review drug to treat breast cancer

Japanese Stocks Rise 0.9%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DSNKY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DSNKY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSNKY\",,,,,undefined,":{"symbol":"DSNKY","market":"US","secType":"STK","nameCN":"Daiichi Sankyo Co., Ltd.","latestPrice":19.0197,"timestamp":1770670800000,"preClose":18.16,"halted":0,"volume":915078,"hourTrading":{"tag":"盘后","latestPrice":19,"preClose":19.0197,"latestTime":"16:00 EST","volume":18000,"amount":342000,"timestamp":1770670817887,"change":-0.0197,"changeRate":-0.001036,"amplitude":0},"delay":15,"changeRate":0.04734030837004406,"floatShares":1809738147,"shares":1850941967,"eps":0.742527,"marketStatus":"Closed","change":0.8597,"latestTime":"02-09 16:00:17 EST Delay","open":18.565,"high":19.04,"low":18.565,"amount":17318836.45780002,"amplitude":0.026156,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.742527,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":18.16,"volumeRatio":0.501882},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSNKY\",,,,,undefined,":{"symbol":"DSNKY","floatShares":1809738147,"roa":"5.46%","roe":"18.27%","lyrEps":0.692127,"volumeRatio":0.501882,"shares":1850941967,"dividePrice":0.442497,"high":19.04,"amplitude":0.026156,"preClose":18.16,"low":18.565,"week52Low":17.8,"pbRate":"3.21","psRate":"2.68","week52High":28.21,"institutionHeld":0.0003,"latestPrice":19.0197,"eps":0.742527,"divideRate":0.023265,"volume":915078,"delay":15,"ttmEps":0.742527,"open":18.565,"prevYearClose":21.24,"prevWeekClose":18.16,"prevMonthClose":18.2,"prevQuarterClose":21.24,"fiveDayClose":19.03,"twentyDayClose":22.99,"sixtyDayClose":22.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSNKY\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"DSNKY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"","dateTimestamp":1722398400000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-30","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706590800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-07-31","symbol":"DSNKY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690776000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSNKY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSNKY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4118,"buy":0.5294,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5294,"analysts":17,"updateTime":1769490000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSNKY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607048873","title":"Daiichi Sankyo Co Q4 EPS $0.30, Same YoY, Sales $3.623B Up From $3.401B YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2607048873","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607048873?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:30","pubTimestamp":1769776214,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo Co (OTC:DSNKY) reported quarterly earnings of $0.30 per share. This is unchanged from the same period last year.  The company reported $3.623 billion in sales this quarter. This is a 6.53 percent increase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/01/50261379/daiichi-sankyo-co-q4-eps-0-30-same-yoy-sales-3-623b-up-from-3-401b-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSNKY","BK4007"],"gpt_icon":0},{"id":"2603676886","title":"Japanese Stocks Climb 1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603676886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603676886?lang=en_us&edition=fundamental","pubTime":"2026-01-14 15:00","pubTimestamp":1768374000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Japan gained Wednesday, as the Nikkei Stock Average gained 1.5% to 54341.23.Taiyo Yuden Co. Ltd. was the biggest gainer during the session, surging 6.9% to Y3,684, and Yaskawa Electric Corp. surged 6.6% to Y5,246. Shiseido Co. Ltd. rounded out the top three movers, as shares surged 5.9% to Y2,615.Dentsu Group Inc. posted the largest decline, dropping 11% to Y3,142, followed by shares of Daiichi Sankyo Co. Ltd., which fell 4.2% to Y3,390. Shares of SoftBank Group Corp. fell 4.2% to Y4,261.On the currency front, the yen strengthened 0.0% against the dollar to Y159.15.In the bond markets, the two-year Japanese government bond yield rose 0.92 basis point to 1.174% and the 10-year JGB yield rose 1.56 basis points to 2.183%. In the U.S., the 10-year Treasury yield fell 1.80 basis point to 4.166%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSNKY","BK4007","SSDOY","BK4183"],"gpt_icon":0},{"id":"2591360603","title":"AstraZeneca, Daiichi Sankyo Drug Gets U.S. Nod for Breast-Cancer Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2591360603","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591360603?lang=en_us&edition=fundamental","pubTime":"2025-12-16 15:16","pubTimestamp":1765869360,"startTime":"0","endTime":"0","summary":"AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.The companies said late Monday that the move will trigger a payment of $150 million from AstraZeneca to Daiichi Sankyo as part of a collaboration deal they reached in 2019.The approval for Enhertu in combination with Roche Holding's Perjeta is for the first-line treatment of adult patients of a form of breast cancer known as HER2-positive for which the tumor can't be removed or in which the disease has spread to other parts of the body, the companies said.The decision was based on the results of late-stage clinical trial that showed the drug combination reduced the risk of disease progression and followed FDA designations of priority review and breakthrough therapy, AstraZeneca and Daiichi Sankyo said.Separate regulatory applications are under review in other countries, the companies added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU0889565916.HKD","AZN","BK4588","LU0109394709.USD","LU1829250122.USD","BK4007","BK4585","LU2236285917.USD","LU0320765992.SGD","LU2417539215.USD","BK4568","LU2462157665.USD","DSNKY"],"gpt_icon":0},{"id":"2588018626","title":"Japanese Stocks Climb 1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588018626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588018626?lang=en_us&edition=fundamental","pubTime":"2025-12-03 15:00","pubTimestamp":1764745200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Japan gained Wednesday, as the Nikkei Stock Average rose 1.1% to 49864.68.SCREEN Holdings Co. Ltd. was the biggest gainer during the session, surging 7.9% to Y14,035, and Lasertec Corp. surged 7.3% to Y30,310. Ebara Corp. rounded out the top three movers, as shares surged 6.7% to Y4,018.Aeon Co. Ltd. posted the largest decline, dropping 6.7% to Y2,580, followed by shares of Daiichi Sankyo Co. Ltd., which fell 4.1% to Y3,561. Shares of Osaka Gas Co. Ltd. fell 3.1% to Y5,305.On the currency front, the yen strengthened 0.2% against the dollar to Y155.60.In the bond markets, the two-year Japanese government bond yield rose 0.15 basis point to 1.017% and the 10-year JGB yield rose 2.98 basis points to 1.892%. In the U.S., the 10-year Treasury yield fell 1.80 basis point to 4.077%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AONNY","BK4155","DSNKY"],"gpt_icon":0},{"id":"2576747770","title":"AstraZeneca, Daiichi’s Datroway demonstrated significant improvement in OS, PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2576747770","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576747770?lang=en_us&edition=fundamental","pubTime":"2025-10-20 00:00","pubTimestamp":1760889610,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announced positive results from the TROPION-Breast02 Phase III trial showed Datroway demonstrated a st...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-daiichis-datroway-demonstrated-significant-improvement-in-os-pfs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-daiichis-datroway-demonstrated-significant-improvement-in-os-pfs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU2462157665.USD","DSNKY","AZN","LU0320765992.SGD","BK4568","BK4195","BK4211","BK4585","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","LU2456880835.USD","PFS","LU2236285917.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2575264786","title":"Japanese Pharma Stocks Could Gain on Revived Investor Sentiment -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2575264786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575264786?lang=en_us&edition=fundamental","pubTime":"2025-10-14 16:23","pubTimestamp":1760430180,"startTime":"0","endTime":"0","summary":"0823 GMT - Japanese pharmaceutical stocks could gain on revived investor sentiment following recent U.S. pharma news, say Macquarie Capital analysts in a note. Pfizer's deal with the U.S. for a three-year tariff reprieve in exchange for lower drug prices was likely better than what investors had expected, prompting a rally in Japanese pharma growth names, Tony Ren and other analysts say. While value and high-dividend Japanese pharmaceutical stocks have outperformed year to date, growth names are likely to now catch up, the analysts say. Likely new Japanese leadership favoring loose monetary policy has also lifted Japanese equities as a whole, they add. Macquarie Capital's marquee buy picks are Chugai Pharmaceutical and Daiichi Sankyo, which have strong drug pipelines and could report higher-than-expected earnings. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0289739699.SGD","SG9999002224.SGD","LU1894683348.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU1066051498.USD","BK4581","BK4592","LU0170899867.USD","BK4599","LU1023059063.AUD","LU0306807586.USD","LU1894683264.USD","LU0234572021.USD","LU0058720904.USD","SG9999011175.SGD","SG9999001176.SGD","BK4534","IE0002270589.USD","IE00B19Z3B42.SGD","BK4588","BK4550","LU0456855351.SGD","BK4568","DSNKY","LU0225771236.USD","SG9999013999.USD","LU0985481810.HKD","LU0868494617.USD","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4533","IE00BLSP4452.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","SG9999001176.USD","BK4007","SG9999002232.USD","LU0321505439.SGD","LU0225284248.USD","LU0306806265.USD","LU1883839398.USD","LU0321505868.SGD","BK4585"],"gpt_icon":1},{"id":"2572530198","title":"AstraZeneca shares leap with FDA set to review drug to treat breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2572530198","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572530198?lang=en_us&edition=fundamental","pubTime":"2025-10-01 22:54","pubTimestamp":1759330440,"startTime":"0","endTime":"0","summary":"AstraZeneca shares rallied on Wednesday after the U.K.-based pharmaceuticals giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.AstraZeneca shares   jumped 7% as it and Daiichi Sankyo , which discovered the drug, said the U.S. regulatory agency will review Enhertu followed by paclitaxel, trastuzumab and pertuzumab to treat stage 2 or stage 3 breast cancer.The target date for an FDA ruling is May 18, 2026.The drug is being jointly developed and commercialized by both companies.A trial showed the combination of drugs demonstrated a statistically significant and clinically meaningful improvement in what's called the pathologic compete response, or pCR, rate when used before surgery in patients with a high risk of early-stage breast cancer.The two companies saw Enhertu sales of $2.29 billion in the first half of the year, as it already is used in treating some forms of breast cancer.AstraZeneca shares also climbed on T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4599","BK4592","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505868.SGD","LU0225771236.USD","LU1894683264.USD","LU0170899867.USD","LU1066053197.SGD","LU0058720904.USD","SG9999003800.SGD","SG9999011175.SGD","BK4585","BK4588","IE000M9KFDE8.USD","SG9999001176.SGD","LU0320765992.SGD","SG9999002232.USD","LU0289739699.SGD","SG9999013999.USD","IE0002270589.USD","BK4581","IE00B19Z3B42.SGD","LU0306807586.USD","LU0889565916.HKD","LU0321505439.SGD","DSNKY","LU1829250122.USD","IE00B19Z3581.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0122379950.USD","BK4534","LU0225284248.USD","LU0985481810.HKD","LU0109394709.USD","LU1023059063.AUD","BK4550","LU1883839398.USD","LU2417539215.USD","LU0868494617.USD","AZN","BK4533","LU2462157665.USD","BK4568","SG9999002224.SGD","LU0306806265.USD"],"gpt_icon":1},{"id":"2566678554","title":"Japanese Stocks Rise 0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566678554","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566678554?lang=en_us&edition=fundamental","pubTime":"2025-09-10 15:00","pubTimestamp":1757487600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Japan rose Wednesday, as the Nikkei Stock Average rose 0.9% to 43837.67.SoftBank Group Corp. was the biggest gainer during the session, surging 7.3% to Y16,280, and Furukawa Electric Co. Ltd. surged 5.7% to Y9,249. Fujikura Ltd. rounded out the top three movers, as shares surged 5.6% to Y13,630.Sumitomo Pharma Co. Ltd. posted the largest decline, falling 4.1% to Y1,676, followed by shares of Mazda Motor Corp., which fell 3.4% to Y1,133. Shares of Daiichi Sankyo Co. Ltd. fell 3.4% to Y3,556.On the currency front, the yen weakened 0.1% against the dollar to Y147.56.In the bond markets, the two-year Japanese government bond yield fell 0.33 basis point to 0.850% and the 10-year JGB yield rose 0.08 basis point to 1.566%. In the U.S., the 10-year Treasury yield rose 0.50 basis point to 4.092%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSNKY","US10Y.BOND","US3Y.BOND","US5Y.BOND","US12M.BOND","US7Y.BOND","US6M.BOND","US2Y.BOND","US30Y.BOND","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}